---
figid: PMC12230322__CIA-20-969-g0001
figtitle: Normobaric hyperoxia (NBO) therapy in acute ischemic stroke (AIS)
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12230322
filename: CIA-20-969-g0001.jpg
figlink: /pmc/articles/PMC12230322/figure/F1/
number: F1
caption: Mechanisms of normobaric hyperoxia (NBO) therapy in acute ischemic stroke
  (AIS). NBO preconditioning increases antioxidant enzyme production, alters mitochondrial
  membrane lipids, increases tumor necrosis factor-alpha (TNF-α) converting enzyme
  levels, stimulates the hypoxia-inducible factor signaling pathway, and upregulate
  glutamate transporters, Na+–Ca+ exchanger, and metabotropic glutamate receptor after
  AIS. NBO postconditioning can reduce infarction volume, improve metabolism, increase
  tissue perfusion, reduce free-radical generation, ameliorate hyperglycolytic cascades,
  maintain mitochondrial function, and preserve blood-brain barrier integrity. Both
  NBO preconditioning and postconditioning reduce infarction volume, ameliorate brain
  edema, and improve neurological deficits
papertitle: Normobaric Hyperoxia Therapy in Treating Stroke
reftext: Yanli Duan, et al. Clin Interv Aging. 2025;20(NA).
year: '2025'
doi: 10.2147/CIA.S521584
journal_title: Clinical Interventions in Aging
journal_nlm_ta: Clin Interv Aging
publisher_name: Dove Press
keywords: normobaric hyperoxia | ischemic stroke | hemorrhagic stroke | penumbra
automl_pathway: 0.7895067
figid_alias: PMC12230322__F1
figtype: Figure
redirect_from: /figures/PMC12230322__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12230322__CIA-20-969-g0001.html
  '@type': Dataset
  description: Mechanisms of normobaric hyperoxia (NBO) therapy in acute ischemic
    stroke (AIS). NBO preconditioning increases antioxidant enzyme production, alters
    mitochondrial membrane lipids, increases tumor necrosis factor-alpha (TNF-α) converting
    enzyme levels, stimulates the hypoxia-inducible factor signaling pathway, and
    upregulate glutamate transporters, Na+–Ca+ exchanger, and metabotropic glutamate
    receptor after AIS. NBO postconditioning can reduce infarction volume, improve
    metabolism, increase tissue perfusion, reduce free-radical generation, ameliorate
    hyperglycolytic cascades, maintain mitochondrial function, and preserve blood-brain
    barrier integrity. Both NBO preconditioning and postconditioning reduce infarction
    volume, ameliorate brain edema, and improve neurological deficits
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DECR1
  - CYBA
  - CYBB
  - DUOX1
  - DUOX2
  - NCF1
  - NCF2
  - NCF4
  - NOX1
  - NOX3
  - NOX4
  - NOX5
  - RAC1
  - NOS1
  - FAM20C
  - TNF
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - SLC2A1
  - PFKM
  - TLX2
  - NOS3
  - ENO4
  - ADAM17
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - SLC9A1
  - AQP4
  - nos1
  - tnfb
  - slc2a1a
  - vegfaa
  - slc9a1b
  - aqp4
  - RNS
  - brain edema
---
